CHRONIC PAIN TREATMENT DURING PREGNANCY: NAVIGATING THE EVIDENCE GREY ZONE
Advancements in Health Research · 06.05.2026 · 3 (s1)
DOI: 10.4081/ahr.2026.157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advancements in Health Research, online erschienen am 06.05.2026. Verfasst von Fondazione Paolo Procacci. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background and Aims. Chronic pain during pregnancy is a significant yet underexplored condition. Low back pain, pelvic girdle pain, neuropathic syndromes, headache, fibromyalgia, and pre-existing chronic pain disorders can considerably impair mobility, sleep, daily functioning, and psychological well-being. Despite this burden, therapeutic decisions remain challenging because maternal needs for symptom control must be balanced against fetal and neonatal safety within a limited and often inconsistent evidence base. This review aims to provide a clinically oriented overview of the main evidence gaps affecting the pharmacological management of chronic pain during pregnancy and to highlight key priorities for future research.
Methods
We performed a narrative review of the existing literature on pharmacological treatment of chronic pain during pregnancy, focusing on five key areas: the availability of pregnancy-specific data, pharmacokinetic evidence, maternal-fetal safety, long-term outcomes for offspring, and the methodological consistency of published studies and recommendations.
Results
Current evidence remains fragmented, heterogeneous, and often indirect. Pharmacokinetic data in pregnant women are limited, long-term neurodevelopmental outcomes are inadequately defined for many common analgesic or adjuvant drugs, and reported endpoints differ significantly across studies. As a result, many treatment decisions are based on extrapolation from non-pregnant populations, trimester-specific precautions, and individualized clinical judgment rather than solid pregnancy-specific guidance. This uncertainty may lead to both the undertreatment of disabling pain and excessive caution in therapy.
Conclusions
Treatment of chronic pain during pregnancy remains an area with limited evidence. There is an urgent need for prospective studies, standardized maternal and fetal outcome measures, and pregnancy-specific, clinician-focused guidelines to promote safer and more personalized pain management.
Zitieren
APA
Procacci, F. P. (2026). CHRONIC PAIN TREATMENT DURING PREGNANCY: NAVIGATING THE EVIDENCE GREY ZONE. Advancements in Health Research, 3(s1). https://doi.org/10.4081/ahr.2026.157
Vancouver
Procacci FP. CHRONIC PAIN TREATMENT DURING PREGNANCY: NAVIGATING THE EVIDENCE GREY ZONE. Advancements in Health Research. 2026;3(s1). doi:10.4081/ahr.2026.157
BibTeX
@article{Procacci2026,
author = {Procacci, Fondazione Paolo},
title = {CHRONIC PAIN TREATMENT DURING PREGNANCY: NAVIGATING THE EVIDENCE GREY ZONE},
journal = {Advancements in Health Research},
year = {2026},
volume = {3},
number = {s1},
doi = {10.4081/ahr.2026.157}
}
EUVIMED